APAC Biotech Pvt.Ltd. is a leading biotechnology company involved in research and development of Dendritic cell based immunotherapy for cancer treatment and manufacturing of APCEDEN®. Our endeavor is to enhance the quality of life and improve the life expectancy of cancer patients by providing a safe and effective dendritic cell based personalised immunotherapy. Our product APCEDEN® has been developed after a thorough research on the principles of immunotherapy. Our active immunotherapies target not only tumour cells, but also the cancer stem cells believed to be the cause of cancer growth and recurrence. Our prime objective is to boost the immune system naturally through our novel dendritic cell based immunotherapy enabling it to fight against malignant tumours.
To find the roots of cancer and to improve the quality of life by immunology based Dendritic cell based therapy.
Our mission is to enrich lives of millions of cancer sufferers by researching and presenting therapeutic solutions, based on immunotherapy.
Continuous Innovation : Our endeavours are directed towards scientific innovation, integrity and the application of the biotechnological intelligencefor the benefit of millions.
Value Creation : We provide value by focusing on immunotherapy that prolongs life span and improves their quality of life.
Ethical Practice : Imparting the highest ethical standards to our formulation, operations and communications is our highest goal.
Quality : To formulate high quality is the cornerstone of all our endeavours.
Transparency : Transparency at all stages is the key note of our undertakings
We have a committed team of qualified scientists and doctors who work round the clock. We have a 1000 class clean room facility, equipped with state of art equipment.